Literature DB >> 6642086

Skeletal muscle in alloxan diabetes. A comparison of isometric contractions in fast and slow muscle.

S F Paulus, J Grossie.   

Abstract

Diabetes was produced by withholding insulin treatment from previously alloxanized female rats. Isometric contraction was assessed in soleus and extensor digitorum longus (EDL) muscles removed 2 h to 32 days after insulin withdrawal. Directly induced contractions were measured in vitro at 20 degrees C. In soleus muscles from severely diabetic rats, average twitch and tetanic forces were normal or slightly greater than that of controls of similar age, whereas in EDL, marked decreases appeared in both twitch and tetanic forces. Soleus muscle from severely diabetic rats was not depolarized as already reported in EDL. After 16 and 32 days in the diabetic state, soleus muscles from moderately diabetic rats generated average tetanic forces that were equal to that found in age-matched controls, whereas EDL tetanic forces were significantly (P = less than 0.01) weaker. Average specific twitch force in diabetic soleus muscles was greater than age-matched controls after 16 and 32 days in the diabetic state. In diabetic soleus muscle, significant increases in the average half relaxation time and twitch duration were seen after prolonged (16 and 32 days) periods of diabetes. No changes were seen in the same temporal parameters of the twitch in diabetic EDL muscle. A greater atrophy appeared in EDL than in soleus after 16 and 32 days of uncontrolled diabetes.

Entities:  

Mesh:

Year:  1983        PMID: 6642086     DOI: 10.2337/diab.32.11.1035

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

1.  Skeletal muscle morphology and contractile function in relation to muscle denervation in diabetic neuropathy.

Authors:  Matti D Allen; Brendan Major; Kurt Kimpinski; Timothy J Doherty; Charles L Rice
Journal:  J Appl Physiol (1985)       Date:  2013-12-19

2.  Effects of streptozotocin-induced diabetes on leg muscle contractile properties and motor neuron morphology in rats.

Authors:  Toru Tamaki; Ken Muramatsu; Masako Ikutomo; Naomi Oshiro; Hisae Hayashi; Masatoshi Niwa
Journal:  Anat Sci Int       Date:  2018-06-06       Impact factor: 1.741

3.  Spatially resolved changes in diabetic rat skeletal muscle metabolism in vivo studied by 31P-n.m.r. spectroscopy.

Authors:  R A Challiss; M J Blackledge; G K Radda
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

4.  The effects of neuropeptide Y on skeletal muscle contractile properties in streptozotocin diabetic rats.

Authors:  M Ljubisavljevic; A Qureshi; N Nagelkerke
Journal:  Mol Cell Biochem       Date:  2009-07-19       Impact factor: 3.396

5.  Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter; S Robertson
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

6.  Diabetic state-induced rapid inactivation of noncontractile Ca2+ mobilization operated by nicotinic acetylcholine receptor in mouse diaphragm muscle.

Authors:  I Kimura; H Tsuneki; K Dezaki; M Kimura
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

7.  Bicarbonate and fast-twitch muscle: evidence for a major role in pH regulation.

Authors:  J Grossie; C Collins; M Julian
Journal:  J Membr Biol       Date:  1988-11       Impact factor: 1.843

8.  Skeletal muscle sorbitol levels in diabetic rats with and without insulin therapy and endurance exercise training.

Authors:  O A Sánchez; T F Walseth; L M Snow; R C Serfass; L V Thompson
Journal:  Exp Diabetes Res       Date:  2009-11-23

9.  Gene expression profiling in the type 1 diabetes rat diaphragm.

Authors:  Erik van Lunteren; Michelle Moyer
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

10.  Hyperglycemia and acquired weakness in critically ill patients: potential mechanisms.

Authors:  Leigh Ann Callahan; Gerald S Supinski
Journal:  Crit Care       Date:  2009-03-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.